Azo Reductase- Activated Colon- Targeting Prodrugs of Aminosalicylates for Inflammatory Bowel Disease: Preparation, Pharmacokinetic and Pharmacodynamic Profile

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 6, 2013-12 ,pp. : 419-432

Bentham Science Publishers

Access to resources Recommend Favorite

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

By Bautzováá Tereza   Rabišškováá Miloslava   Lamprecht Alf  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 9, 2011-09 ,pp. : 1100-1109

Informa Healthcare

Access to resources Recommend Favorite

Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease

By Malayandi Rajkumar   Kondamudi Phani   Ruby P.   Aggarwal Deepika  

Drug Delivery and Translational Research, Vol. 4, Iss. 2, 2014-04 ,pp. : 187-202

Springer Publishing Company

Access to resources Recommend Favorite

Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Prodrugs for the Treatment of Colonic Diseases Based on 5-Aminosalicylic Acid, 4'-eranyloxyferulic Acid, and Auraptene: Biological Activities and Analytical Assays

By  

Current Drug Delivery, Vol. 9, Iss. 2, 2012-03 ,pp. : 112-121

Bentham Science Publishers

Access to resources Recommend Favorite